The Icahn School of Medicine at Mount Sinai, internationally renowned for its research, educational, and clinical care programs, has been named a member of the Women’s Health Network at the Milken Institute.
The Women’s Health Network brings together more than 100 organizations in a global collaborative that is committed to advancing existing and new efforts in women’s health research, innovation, and investment. It is chaired by former First Lady of the United States Jill Biden, EdD, and guided by a steering committee of business, health, philanthropy, and technology leaders.
“For years, innovation in health care diagnosis and treatment has resulted in benefits for millions of people, but that has largely occurred without significant involvement from women,” said Joanne L. Stone, MD, MSHCDL, Professor and Ellen and Howard C. Katz Chair of the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai. “Even today, there are health challenges that women continue to face across their lifespan, but it also means there are tremendous opportunities to thoughtfully address them. Mount Sinai is exploring that potential through continuous collaboration with experts from diverse specialties across the entire Mount Sinai Health System, forging a revolutionary multidisciplined approach to women’s health. We are proud to bring our insights and expertise to the Women’s Health Network and the Milken Institute to ensure that emerging medical policies, technologies, and research meet the needs of women everywhere.”
The invitation to join the Women’s Health Network recognizes the efforts of the Icahn School of Medicine at Mount Sinai to advance women’s health through cutting-edge research that fills knowledge gaps and contributes to compassionate care for patients. The Icahn School is home to The Blavatnik Family Women’s Health Research Institute, which has expertise in obstetrics, gynecology, reproductive science, population health science and policy, cardiology, psychiatry, and radiation oncology. Under the leadership of Dr. Stone, an internationally recognized physician-scientist with expertise in fetal imaging and caring for high-risk pregnancies, the Mount Sinai-Rainbow Clinic became the nation’s first multidisciplinary specialty clinic to provide enhanced clinical care and psychological support for women who have experienced stillbirth.
Furthering the effort to redefine the experience of women’s medical care through a seamless, empowering, and personalized treatment journey, the Carolyn Rowan Center for Women’s Health and Wellness at Mount Sinai will open in 2026. The Center will take an integrative approach to women’s health to deliver proactive and transformative care that is supportive across the lifespan through innovative care pathways, novel treatments, research, and actionable insights that help close the gender health gap. This holistic treatment approach combines traditional medicine, such as the specialties of gynecology, cardiology, and psychiatry, with alternative-medicine techniques including acupuncture and mind-body practices.
Mount Sinai will bring its extensive expertise in the integration of clinical excellence, research innovation, and comprehensive care to the Women’s Health Network at the Milken Institute, continuing a longstanding commitment to overall health and wellness for women.
“From its beginnings, Mount Sinai has been committed to providing care that is life-changing and accessible for everyone,” said Eric J. Nestler, MD, PhD, the Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai. “The opportunity to become an inaugural member of the Women’s Health Network enables us to continue that mission on a much larger scale that will have far-reaching impacts. We are honored to be part of this network and to be contributing to new policies and approaches that will result in real action on women’s health, both here in the communities we serve and around the world.”
About the Icahn School of Medicine at Mount Sinai
The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the seven member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to New York City’s large and diverse patient population.
The Icahn School of Medicine at Mount Sinai offers highly competitive MD, PhD, MD-PhD, and master’s degree programs, with enrollment of more than 1,200 students. It has the largest graduate medical education program in the country, with more than 2,700 clinical residents and fellows training throughout the Health System. Its Graduate School of Biomedical Sciences offers 13 degree-granting programs, conducts innovative basic and translational research, and trains more than 560 postdoctoral research fellows.
Ranked 11th nationwide in National Institutes of Health (NIH) funding, the Icahn School of Medicine at Mount Sinai is among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges. More than 4,500 scientists, educators, and clinicians work within and across dozens of academic departments and multidisciplinary institutes with an emphasis on translational research and therapeutics. Through Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai.
-------------------------------------------------------
* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.